Melphalan is an alkylating agent of the nitrogen mustard class, primarily used as a chemotherapy treatment for multiple myeloma and certain types of ovarian cancer. Its mechanism involves the formation… Read more






Melphalan is an alkylating agent of the nitrogen mustard class, primarily used as a chemotherapy treatment for multiple myeloma and certain types of ovarian cancer. Its mechanism involves the formation of reactive intermediates that bind to DNA, inducing cross-links that inhibit replication and transcription in malignant cells. This category provides comprehensive analytical support for laboratories working with this drug, including Melphalan reference standards, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These high-quality materials are essential for accurate impurity profiling, rigorous analytical method validation, and consistent quality control throughout the pharmaceutical development and manufacturing lifecycle. Researchers rely on these well-characterized standards to perform stability testing, quantitative analysis, and regulatory-compliant degradation studies, ensuring the safety and efficacy of the final medicinal product.